comprehensive
Previous article:
FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article: In boost for rare disease push, AstraZeneca to buy Amolyt Pharma
Next article: In boost for rare disease push, AstraZeneca to buy Amolyt Pharma
entertainment
explore
-
Readout LOUD podcast: ALS dilemma, first MASH drug, and more
2025-09-29 23:40 -
Change Healthcare outage fallout shows need for new oversight
2025-09-29 23:01 -
As AI in medicine takes off, can 'human in the loop' prevent harm?
2025-09-29 22:37 -
Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO
2025-09-29 22:02 -
In boost for rare disease push, AstraZeneca to buy Amolyt Pharma
2025-09-29 21:47 -
Why depression after traumatic brain injury is distinct
2025-09-29 21:23